This week, a treatment for retinitis pigmentosa receives orphan drug status, the OMNI platform becomes the first MIGS device cleared for open-angle glaucoma and researchers integrate biosensors into soft contact lenses. Source: AAO
This study estimated the economic and environmental impact of single-use applanation tonometer prisms and gonioscopy lenses at an ophthalmology outpatient service. Source: AAO
This prospective randomized trial evaluated the efficacy of phacoemulsification combined with either endocycloplasty (ECPL) or trabeculectomy for primary angle-closure glaucoma. Source: AAO
The authors evaluated ocular donor tissues from a COVID-19 postmortem donor. Source: AAO
This study describes the posterior segment manifestations of Ebola survivors in Sierra Leone. Source: AAO
This week, Glaukos’ investigational epi-on CXL therapy shows promise in phase 3 trials, a new dry eye drug shows an excellent safety profile and contacts infused with gold nanoparticles may help manage red-green color blindness. Source: AAO
This prospective study compared the performance of retinal specialists and artificial intelligence (AI) algorithm in detecting retinal fluid from spectral-domain OCT scans. Source: AAO
This retrospective, comparative, nonrandomized study assessed several approaches for managing patients with moderate to severe thyroid-associated orbitopathy. Source: AAO
Researchers characterized orbital roof fractures in adults who presented at a single level 1 tertiary care center between 2015 and 2018. Source: AAO
Researchers assessed whether the use of routine preoperative testing leads to delayed surgery and falls in Medicare beneficiaries awaiting cataract surgery. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
